At 29.1% CAGR, the North America Vitamin K2 Market is projected to be worth US$ 494.38 million by 2030, says Business Market Insights

According to Business Market Insights research, the North America vitamin K2 market was valued at US$ 63.89 million in 2022 and is expected to reach US$ 494.38 million by 2030, registering a CAGR of 29.1% from 2022 to 2030. Regulatory consideration and standards and increasing prevalence of CVD are among the critical factors attributed to the North America vitamin K2 market expansion.

As the popularity of vitamin K2 grows, regulatory bodies are likely to establish specific guidelines and standards for manufacturing, labeling, and marketing vitamin K2 products. Regulatory bodies might collaborate closely with key players in the sector to create and implement rules that guarantee the consistency and dependability of vitamin K2 supplements and fortified meals sold in the market. These rules safeguard customers by providing accurate information about the components and advantages of vitamin K2 products. Additionally, such regulations can ensure the quality, safety, and accurate representation of vitamin K2 in the market, providing consumers with reliable and transparent information. For instance, there are various authorities such as FDA is responsible for the approval and supervision of food, drugs and health product in US. The developed countries have a clear legal framework for functional and health claims involving either nutrient or non-nutrient components. Furthermore, establishing evidence-based recommendations for vitamin K2 supplementation requires cooperation between regulatory bodies, research organizations, and industry specialists. To develop safety standards for populations, such as children, expectant mothers, or people with certain medical conditions, regulatory authorities will conduct research and consult experts to determine the proper dosage levels, identify any interactions or contraindications, and set safety guidelines regarding the consumption of vitamin K2. The scientific data supporting the various advantages of vitamin K2, such as its contribution to bone and cardiovascular health, can be examined to decide whether claims must be displayed on product labels or not. This makes it possible to guarantee that health claims are truthful and backed by solid scientific evidence, ensuring customers are not deceived. Thus, the growing focus on regulatory consideration and standards provides significant opportunities for the growth of the North America Vitamin K2 market.

On the contrary, limited awareness regarding benefits of vitamin K2 hampers the North America vitamin K2 market.

Based on product, the North America vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held 65.7% share of North America vitamin K2 market in 2022, amassing US$ 41.96 million. It is projected to garner US$ 330.40 million by 2030 to expand at 29.4% CAGR during 2022-2030.

Based on dosage forms, the North America vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held 51.5% share of North America vitamin K2 market in 2022, amassing US$ 32.91 million. It is projected to garner US$ 259.49 million by 2030 to expand at 29.4% CAGR during 2022-2030.

Based on source, the North America vitamin K2 market is segmented into natural and synthetic. The natural segment held 80.4% share of North America vitamin K2 market in 2022, amassing US$ 51.34 million. It is projected to garner US$ 401.65 million by 2030 to expand at 29.3% CAGR during 2022-2030.

Based on application, the North America vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held 70.5% share of North America vitamin K2 market in 2022, amassing US$ 45.04 million. It is projected to garner US$ 341.77 million by 2030 to expand at 28.8% CAGR during 2022-2030.

Based on country, the North America vitamin K2 market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 84.2% share of North America vitamin K2 market in 2022. It was assessed at US$ 53.77 million in 2022 and is likely to hit US$ 410.97 million by 2030, exhibiting a CAGR of 28.9% during 2022-2030.

Key players operating in the North America vitamin K2 market are Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com